This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
This is a test.
Charting the cellular spacial landscape in rare ovarian cancer
This is a test.
Testing a novel treatment target in clear cell ovarian cancer
This is a test.
Anti-estrogen therapy and ER/PR expression in low-grade serous ovarian cancer
This is a test.
Testing a novel HER2-targeted combination treatment for ovarian cancer
This is a test.
Syngeneic mouse models: tools to study immune-based treatments for ovarian cancer
This is a test.
Metabolic Gene-Edited CAR-T Cells For Ovarian Cancer Treatment
This is a test.
ES2 trial: combining a PARP inhibitor and apoptosis sensitizer
This is a test.
Building a scientific toolbox to study low-grade serous ovarian cancer
This is a test.
Every Woman Study: Canadian Edition
This is a test.
Phase II clinical trial of CX5461 at the time of disease progression on a PARP inhibitor
